[go: up one dir, main page]

AU2003219420A1 - Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera - Google Patents

Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera

Info

Publication number
AU2003219420A1
AU2003219420A1 AU2003219420A AU2003219420A AU2003219420A1 AU 2003219420 A1 AU2003219420 A1 AU 2003219420A1 AU 2003219420 A AU2003219420 A AU 2003219420A AU 2003219420 A AU2003219420 A AU 2003219420A AU 2003219420 A1 AU2003219420 A1 AU 2003219420A1
Authority
AU
Australia
Prior art keywords
treatment
tyrosine kinase
kinase inhibitors
receptor tyrosine
polycythemia vera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003219420A
Inventor
Hagop Kantarjian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU2003219420A1 publication Critical patent/AU2003219420A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003219420A 2002-04-24 2003-04-22 Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera Abandoned AU2003219420A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37514302P 2002-04-24 2002-04-24
US60/375,143 2002-04-24
PCT/IB2003/001632 WO2003090750A1 (en) 2002-04-24 2003-04-22 Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera

Publications (1)

Publication Number Publication Date
AU2003219420A1 true AU2003219420A1 (en) 2003-11-10

Family

ID=29270597

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003219420A Abandoned AU2003219420A1 (en) 2002-04-24 2003-04-22 Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera

Country Status (2)

Country Link
AU (1) AU2003219420A1 (en)
WO (1) WO2003090750A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094785B1 (en) * 2002-12-18 2006-08-22 Cornell Research Foundation, Inc. Method of treating polycythemia vera
WO2006040779A2 (en) * 2004-10-11 2006-04-20 Natco Pharma Limited Controlled release gastric floating matrix formulation containing imatinib

Also Published As

Publication number Publication date
WO2003090750A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
AU2003206785A1 (en) Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
AU2003299651A1 (en) Tyrosine kinase inhibitors
AU2003298942A1 (en) Tyrosine kinase inhibitors
AU2003209340A1 (en) Predictor sets for tyrosine kinase pathways
AU2004272348A1 (en) Quinazoline derivatives as tyrosine kinase inhibitors
AU2003282891A1 (en) Novel tyrosine kinases inhibitors
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
AU2003273842A1 (en) Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors
IL174948A0 (en) Imidazopyrazine tyrosine kinase inhibitors
WO2007064797A3 (en) Inhibitors of c-met and uses thereof
AU2002334355A1 (en) Protein tyrosine kinase inhibitors
EP1670466A4 (en) Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
AU2003275282A1 (en) Novel tyrosine kinase inhibitors
IL166625A0 (en) Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer
AU2002348394A1 (en) Tyrosine kinase inhibitors
AU2002348020A1 (en) Tyrosine kinase inhibitors
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2002348393A1 (en) Tyrosine kinase inhibitors
AU2002323406A1 (en) Tyrosine kinase inhibitors
PL376255A1 (en) Quinazoline derivatives as src tyrosine kinase inhibitors
AU2002327534A1 (en) Tyrosine kinase inhibitors
AU2003219420A1 (en) Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera
AU2003238057A1 (en) Human receptor tyrosine kinase mertk
AU2002253350A1 (en) 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
GB2410744B (en) Kinase inhibitors for the treatment of disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase